Back to search

Article

Candidate biomarkers and gene modules investigation for bone tumor samples derived from castration-resistant prostate cancer bone metastasis patients using WGCNA

2019-11-14

Abstract excerpt

<title>Abstract</title> <p>Background About 80-90% of castration-resistant prostate cancer (CRPC) patients would develop bone metastasis, which leads to the disorder of bone metabolism and induces skeletal related events. However, except for the few approved radiotherapeutic and chemotherapy drugs, like radium-223 and denosumab, there is still lack of effective treatment targeting the bone metastatic tumor. It is...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
755e9fa1-1c89-51d2-9531-c137f3755776
DOI
10.21203/rs.2.17291/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Candidate biomarkers and gene modules investigation for bone tumor samples derived from castration-resistant prostate cancer bone metastasis patients using WGCNADOI 10.21203/rs.2.17291/v1
Select a neighboring publication to make it the new centre.